Latest News - Aclaris

Friday, March 09, 2018

Aclaris Therapeutics Receives US Patent Covering a JAK Inhibitor for Treating Hair Loss Disorders

The United States Patent and Trademark Office (USPTO) issued US Patent No. 9,895,301, which is directed to methods related to the use and administration of a certain janus kinase (JAK) inhibitor for t…

Read the full story